Problems in the treatment of dyshormonal breast hyperplasia: current aspects

E. A. Sukhareva; Сухарева Е. А.; S. V. Kozlov; Козлов С. В.; A. V. Gailis; Гайлис А. В.

doi:10.17650/1994-4098-2010-0-3-11-15

Problems in the treatment of dyshormonal breast hyperplasia: current aspects

Authors: Sukhareva E.A.¹, Kozlov S.V.², Gailis A.V.¹
Affiliations:
1. Town Polyclinic One, Suzran Municipal District, Samara Region
2. Samara State Medical University
Issue: No 3 (2010)
Pages: 11-15
Section: MAMMOLOGY. TREATMENT
Published: 28.08.2010
URL: https://ojrs.abvpress.ru/ojrs/article/view/242
DOI: https://doi.org/10.17650/1994-4098-2010-0-3-11-15
ID: 242

Cite item

Full Text

Abstract
About the authors
References
Supplementary files
Statistics

Abstract

Chemoprophylaxis involving the use of pharmacological or natural agents to prevent cancer is a promising line for the secondary preven- tion of breast cancer.
Positive results as clinical improvement and attenuated breast epithelial dysplasia were obtained while treating with combined oral con- traceptives in 33.3–90%, with gestagens in 87-90%, with estrogens in 87–92%, with androgens in 64–89%, and with antiestrogens in 82–92% of women with benign dyshormonal diseases.